Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Biological characterization of a novel hybrid copolymer carrier system based on glycogen

M. Jirátová, A. Pospíšilová, M. Rabyk, M. Pařízek, J. Kovář, A. Gálisová, M. Hrubý, D. Jirák,

. 2018 ; 8 (1) : 73-82.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19001093

Grantová podpora
NV15-25781A MZ0 CEP - Centrální evidence projektů

The effective drug delivery systems for cancer treatment are currently on high demand. In this paper, biological behavior of the novel hybrid copolymers based on polysaccharide glycogen were characterized. The copolymers were modified by fluorescent dyes for flow cytometry, confocal microscopy, and in vivo fluorescence imaging. Moreover, the effect of oxazoline grafts on degradation rate was examined. Intracellular localization, cytotoxicity, and internalization route of the modified copolymers were examined on HepG2 cell line. Biodistribution of copolymers was addressed by in vivo fluorescence imaging in C57BL/6 mice. Our results indicate biocompatibility, biodegradability, and non-toxicity of the glycogen-based hybrid copolymers. Copolymers were endocyted into the cytoplasm, most probably via caveolae-mediated endocytosis. Higher content of oxazoline in polymers slowed down cellular uptake. No strong colocalization of the glycogen-based probe with lysosomes was observed; thus, it seems that the modified externally administered glycogen is degraded in the same way as an endogenous glycogen. In vivo experiment showed relatively fast biodistribution and biodegradation. In conclusion, this novel nanoprobe offers unique chemical and biological attributes for its use as a novel drug delivery system that might serve as an efficient carrier for cancer therapeutics with multimodal imaging properties.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001093
003      
CZ-PrNML
005      
20201014160715.0
007      
ta
008      
190107s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13346-017-0436-x $2 doi
035    __
$a (PubMed)29134553
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jirátová, Markéta, $d 1990- $7 xx0252774 $u Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, 140 21, Prague 4, Czech Republic. Department of Physiology, Faculty of Science, Charles University in Prague, Viničná 7, 128 44, Praha 2, Czech Republic.
245    10
$a Biological characterization of a novel hybrid copolymer carrier system based on glycogen / $c M. Jirátová, A. Pospíšilová, M. Rabyk, M. Pařízek, J. Kovář, A. Gálisová, M. Hrubý, D. Jirák,
520    9_
$a The effective drug delivery systems for cancer treatment are currently on high demand. In this paper, biological behavior of the novel hybrid copolymers based on polysaccharide glycogen were characterized. The copolymers were modified by fluorescent dyes for flow cytometry, confocal microscopy, and in vivo fluorescence imaging. Moreover, the effect of oxazoline grafts on degradation rate was examined. Intracellular localization, cytotoxicity, and internalization route of the modified copolymers were examined on HepG2 cell line. Biodistribution of copolymers was addressed by in vivo fluorescence imaging in C57BL/6 mice. Our results indicate biocompatibility, biodegradability, and non-toxicity of the glycogen-based hybrid copolymers. Copolymers were endocyted into the cytoplasm, most probably via caveolae-mediated endocytosis. Higher content of oxazoline in polymers slowed down cellular uptake. No strong colocalization of the glycogen-based probe with lysosomes was observed; thus, it seems that the modified externally administered glycogen is degraded in the same way as an endogenous glycogen. In vivo experiment showed relatively fast biodistribution and biodegradation. In conclusion, this novel nanoprobe offers unique chemical and biological attributes for its use as a novel drug delivery system that might serve as an efficient carrier for cancer therapeutics with multimodal imaging properties.
650    _2
$a zvířata $7 D000818
650    _2
$a nosiče léků $x aplikace a dávkování $x farmakokinetika $7 D004337
650    _2
$a endocytóza $7 D004705
650    _2
$a fluorescein-5-isothiokyanát $x aplikace a dávkování $x farmakokinetika $7 D016650
650    _2
$a fluorescenční barviva $x aplikace a dávkování $x farmakokinetika $7 D005456
650    _2
$a glykogen $x aplikace a dávkování $x farmakokinetika $7 D006003
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a heterocyklické sloučeniny $x aplikace a dávkování $x farmakokinetika $7 D006571
650    _2
$a lidé $7 D006801
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a organokovové sloučeniny $x aplikace a dávkování $x farmakokinetika $7 D009942
650    _2
$a polyaminy $x aplikace a dávkování $x farmakokinetika $7 D011073
650    _2
$a tkáňová distribuce $7 D014018
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pospíšilová, Aneta $u Institute of Macromolecular Chemistry of the Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
700    1_
$a Rabyk, Mariia, $d 1987- $7 xx0252775 $u Institute of Macromolecular Chemistry of the Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
700    1_
$a Pařízek, Martin $u Institute of Physiology of the Academy of Sciences of the Czech Republic, Videnska 1083, 142 20, Prague 4, Czech Republic.
700    1_
$a Kovář, Jan $u Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, 140 21, Prague 4, Czech Republic.
700    1_
$a Gálisová, Andrea $u Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, 140 21, Prague 4, Czech Republic. Institute of Biophysics and Informatics, 1st Medicine Faculty Charles University, Salmovská 1, 12000, Prague 2, Czech Republic.
700    1_
$a Hrubý, Martin $u Institute of Macromolecular Chemistry of the Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
700    1_
$a Jirák, Daniel $u Institute for Clinical and Experimental Medicine (IKEM), Videnska 1958/9, 140 21, Prague 4, Czech Republic. daji@ikem.cz. Institute of Biophysics and Informatics, 1st Medicine Faculty Charles University, Salmovská 1, 12000, Prague 2, Czech Republic. daji@ikem.cz.
773    0_
$w MED00197253 $t Drug delivery and translational research $x 2190-3948 $g Roč. 8, č. 1 (2018), s. 73-82
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29134553 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20201014160646 $b ABA008
999    __
$a ok $b bmc $g 1364000 $s 1039216
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 8 $c 1 $d 73-82 $i 2190-3948 $m Drug delivery and translational research $n Drug Deliv Transl Res $x MED00197253
GRA    __
$a NV15-25781A $p MZ0
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...